Delivery Order SPE2DB20D3303-SPE2DB25FZ8C1
Award Date
5/15/25
Potential Completion Date
5/16/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a ceiling value of $1,088.36 and a period of performance through May 12, 2025. This contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a ceiling value of $1,555.96 and a completion date of April 18, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a ceiling value of $3,957.07 and a period of performance through April 30, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a ceiling value of $4,723.08 and a period of performance through May 5, 2025. The contract is not set aside and was awarded on May 2, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,909.55 firm fixed-price contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of April 22, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract is a firm fixed-price delivery order with a ceiling value of $7,076.16 and a performance period through May 5, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. This delivery order is part of a larger Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,609.07, is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a period of performance through May 2, 2025 and is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The delivery order has a ceiling value of $3,105.00 and a period of performance through May 19, 2025. The contract is a firm fixed price arrangement, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The award has a ceiling value of $1,920.93 and a period of performance through May 19, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,632.54 contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...